Okogen, Inc. Email Format

Biotechnology ResearchTexas, United States2-10 Employees

Okogen, Inc. is a private biotechnology company based in Plano, Texas, focused on developing novel therapeutics to address unmet needs in ophthalmic infectious diseases. The organization concentrates on advancing a Phase 2b clinical program for acute infectious conjunctivitis and is pursuing an AI-assisted evaluation tool aimed at improving patient care, illustrating a blend of therapeutic development with digital health support. The company describes its work around a single primary product concept intended to cover multiple forms of acute infectious conjunctivitis, reflecting its strategic emphasis on a unified treatment approach. Okogen operates in the biotechnology research sector, aligning with a niche within ophthalmology that targets infectious eye conditions and seeks to enhance clinical decision-making and patient outcomes. The company is relatively small in size and has recently relocated its headquarters to Plano, with activity expanding in the United States and a growing clinical program underway.

Sign up for free to view info

Company overview Employee directory